Huadong Medicine Co Ltd
SZSE:000963
Huadong Medicine Co Ltd
Net Income (Common)
Huadong Medicine Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Huadong Medicine Co Ltd
SZSE:000963
|
Net Income (Common)
¥2.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
17%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Net Income (Common)
¥8.9B
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
15%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Net Income (Common)
¥3.8B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Net Income (Common)
¥2.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Net Income (Common)
¥2.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
18%
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
See Also
What is Huadong Medicine Co Ltd's Net Income (Common)?
Net Income (Common)
2.7B
CNY
Based on the financial report for Sep 30, 2023, Huadong Medicine Co Ltd's Net Income (Common) amounts to 2.7B CNY.
What is Huadong Medicine Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
17%
Over the last year, the Net Income (Common) growth was 13%. The average annual Net Income (Common) growth rates for Huadong Medicine Co Ltd have been -3% over the past three years , 5% over the past five years , and 17% over the past ten years .